FOXD1 acts as a carcinogenic transcription factor in cancers such as metastatic melanoma and renal clear cell sarcoma (Bond et al., 2021; Li et al., 2019; Pan, Li & Chen, 2018; Zhang et al., 2020; Zhao et al., 2015). Here, FOXD1 is linked to metastatic melanoma.